Literature DB >> 25966919

What physicians need to know about renal function in outpatients with heart failure.

Bård Waldum-Grevbo1.   

Abstract

The majority of outpatients with heart failure (HF) have chronic kidney disease (CKD) as an important comorbidity. Both glomerular filtration rate and abnormal urinary albumin excretion are major predictors of outcome in HF patients. Despite this, patients with renal dysfunction have been systematically excluded from the large randomized HF trials. There is lack of evidence for optimal treatment in these cardiorenal patients and treatment nihilism may account in part for their bad prognosis. Identifying and monitoring the progression of renal disease and making an effort to preserve renal function should be an important task in the management of all patients with HF. In this review, the current understanding of the pathophysiology of renal dysfunction in outpatients with HF will be summarized. Furthermore, important principles of the identification and management of cardiorenal patients will be described in order to make the physician more capable of managing outpatients with HF and renal dysfunction.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25966919     DOI: 10.1159/000381012

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  2 in total

1.  Is it time for a multi-specialty approach to cardio-renal dysfunction in children with cyanotic congenital heart disease?

Authors:  Tanya Holt; Guido Filler
Journal:  Pediatr Nephrol       Date:  2017-10-02       Impact factor: 3.714

2.  Characterization of baseline clinical factors associated with incident worsening kidney function in patients with non-valvular atrial fibrillation: the Hokuriku-Plus AF Registry.

Authors:  Kenshi Hayashi; Yoshihiro Tanaka; Toyonobu Tsuda; Akihiro Nomura; Noboru Fujino; Hiroshi Furusho; Norihiko Sakai; Yasunori Iwata; Soichiro Usui; Kenji Sakata; Takeshi Kato; Hayato Tada; Takashi Kusayama; Keisuke Usuda; Masa-Aki Kawashiri; Rod S Passman; Takashi Wada; Masakazu Yamagishi; Masayuki Takamura
Journal:  Heart Vessels       Date:  2022-10-17       Impact factor: 1.814

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.